Ivanov, V. Et Al. 2022. Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia. FUTURE ONCOLOGY , vol.18, no.26 , 2879-2889.

Ivanov, V., Yeh, S., Mayer, J., Saini, L., ÜNAL, A., Boyiadzis, M., ... Hoffman, D. M.(2022). Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia. FUTURE ONCOLOGY , vol.18, no.26, 2879-2889.

Ivanov, Vladimir Et Al. "Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia," FUTURE ONCOLOGY , vol.18, no.26, 2879-2889, 2022

Ivanov, Vladimir Et Al. "Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia." FUTURE ONCOLOGY , vol.18, no.26, pp.2879-2889, 2022

Ivanov, V. Et Al. (2022) . "Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia." FUTURE ONCOLOGY , vol.18, no.26, pp.2879-2889.

@article{article, author={Vladimir Ivanov Et Al. }, title={Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia}, journal={FUTURE ONCOLOGY}, year=2022, pages={2879-2889} }